Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ulna metaphyseal dysplasia syndrome is a rare primary bone dysplasia characterized by dysplasia of the distal ulnar metaphyses, as well as metacarpal/metatarsal dysplasia and metaphyseal changes resembling enchondromata. Patients usually present bony swelling of the wrists with or without pain (knees and ankles may also be affected). Other variably associated features include platyspondyly, skeletal development delay, short stature and coxa valga.
Features include: Coxa valga, Delayed skeletal maturation, Abnormality of the vertebral column, and Hypercalcemia and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 2 | Delayed skeletal maturation, Abnormality of the vertebral column |
Biomarker and diagnostic research for ulna metaphyseal dysplasia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ulna metaphyseal dysplasia syndrome.
126 publications have been identified in PubMed for ulna metaphyseal dysplasia syndrome. Research spans Review / Meta-Analysis (68%), Basic Science / Preclinical (15%), and Epidemiology / Natural History (6%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 86 | 68% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 5:38 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
19 |
15% |
Disease patterns and progression | 7 | 6% |
Patient case studies | 6 | 5% |
Other research | 3 | 2% |
Testing and diagnosis research | 3 | 2% |
Clinical study results | 2 | 2% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Lin S (2026). [PMID: 41517791](https://pubmed.ncbi.nlm.nih.gov/41517791/). *Medicine (Baltimore)*. [Case Report / Case Series]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Sullivan MM (2025). [PMID: 40153327](https://pubmed.ncbi.nlm.nih.gov/40153327/). *Clin Exp Rheumatol*. [Review / Meta-Analysis]
Merendino A (2025). [PMID: 40080340](https://pubmed.ncbi.nlm.nih.gov/40080340/). *Eur Geriatr Med*. [Review / Meta-Analysis]
Molteni R (2025). [PMID: 40195449](https://pubmed.ncbi.nlm.nih.gov/40195449/). *Nat Med*. [Other]
Gencer NS (2025). [PMID: 41291504](https://pubmed.ncbi.nlm.nih.gov/41291504/). *BMC Geriatr*. [Epidemiology / Natural History]
Ma R (2025). [PMID: 40992234](https://pubmed.ncbi.nlm.nih.gov/40992234/). *J Clin Anesth*. [Review / Meta-Analysis]